Abstract
Outpatient parenteral antimicrobial therapy (OPAT) has been recognised as a useful, cost-effective and safe alternative to inpatient treatment, but no formal OPAT unit existed in Switzerland until recently. In December 2013 an OPAT unit was established at Lausanne University Hospital. We review here the experience of this new OPAT unit after 18 months of activity. Patient characteristics, clinical activities and outcomes were recorded prospectively. Need and acceptance was evaluated as number of OPAT courses administered and number of patients refusing OPAT. Safety and efficacy were evaluated as: (1) adverse events linked to antimicrobials and catheters, (2) re-admission to hospital, (3) rate of treatment failures and (4) mortality. Over 18 months, 179 courses of OPAT were administered. Acceptance was high with only four patients refusing OPAT. Urinary tract infections with resistant bacteria and musculoskeletal infections were the most common diagnoses. Self-administration of antibiotics using elastomeric pumps became rapidly the most frequently used approach. Sixteen patients presented with adverse events linked to antimicrobials and catheters. OPAT-related readmissions occurred in nine patients. The overall cure rate was 94 %. This study shows that OPAT is very well accepted by patients and medical staff, even in a setting which has not used this type of treatment approach until now. Self-administration using elastomeric pumps proved to be particularly useful, safe and efficient. OPAT offers a good alternative to hospitalisation for patients presenting with infections due to resistant bacteria that cannot be treated orally anymore and for difficult to treat infections.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Rucker RW, Harrison GM (1974) Outpatient intravenous medications in the management of cystic fibrosis. Pediatrics 54:358–360
Barr DA, Semple L, Seaton RA (2012) Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years. Int J Antimicrob Agents 39:407–413
Seetoh T, Lye DC, Cook AR et al (2013) An outcomes analysis of outpatient parenteral antibiotic therapy (OPAT) in a large Asian cohort. Int J Antimicrob Agents 41:569–573
Subedi S, Looke DFM, McDougall DA et al (2015) Supervised self-administration of outpatient parenteral antibiotic therapy: a report from a large tertiary hospital in Australia. Int J Infect Dis 30:161–165
Tice AD, Rehm SJ, Dalovisio JR et al (2004) Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA Guide Clin Infect Dis 38:1651–1672
Chapman ALN, Seaton RA, Cooper MA et al (2012) Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement. J Antimicrob Chemother 67:1053–1062
Galpérine T, Ader F, Piriou P et al (2006) Outpatient parenteral antimicrobial therapy (OPAT) in bone and joint infections. Méd Mal Infect 36:132–137
Matthews PC, Conlon CP, Berendt AR et al (2007) Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years. J Antimicrob Chemother 60:356–362
Howden BP, Richards MJ (2001) The efficacy of continuous infusion flucloxacillin in home therapy for serious staphylococcal infections and cellulitis. J Antimicrob Chemother 48:311–314
Walton AL, Howden BP, Grayson LM et al (2007) Continuous-infusion penicillin home-based therapy for serious infections due to penicillin-susceptible pathogens. Int J Antimicrob Agents 29:544–548
Prescott WA Jr, Gentile AE, Nagel JL et al (2011) Continuous-infusion antipseudomonal Beta-lactam therapy in patients with cystic fibrosis. P T Peer Rev J Form Manag 36:723–763
Nathwani D, Zambrowski J-J (2000) Advisory group on Home-based and Outpatient Care (AdHOC): an international consensus statement on non-inpatient parenteral therapy. Clin Microbiol Infect 6:464–476
Paladino JA, Poretz D (2010) Outpatient parenteral antimicrobial therapy today. Clin Infect Dis 51:S198–S208
Walker SE, Iazzetta J, Law S et al (2010) Stability of commonly used antibiotic solutions in an elastomeric infusion device. Can J Hosp Pharm 63:212–224
Dellamorte Bing C, Nowobilski-Vasilios A (2015) Extended stability for parenteral drugs. 5th edn. American Society of Health-System Pharmacists
Upton A, Ellis-Pegler R, Woodhouse A (2004) Outpatient parenteral antimicrobial therapy (OPAT): a review of experience at Auckland Hospital. NZ Med J 117:U1020
Nguyen HH (2010) Hospitalist to home: outpatient parenteral antimicrobial therapy at an academic center. Clin Infect Dis 51(Suppl 2):S220–S223
Allison GM, Muldoon EG, Kent DM et al (2014) Prediction model for 30-day hospital readmissions among patients discharged receiving outpatient parenteral antibiotic therapy. Clin Infect Dis 58:812–819
Meier S, Weber R, Zbinden R et al (2011) Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. Infection 39:333–340
Carro G, Lawton J, Harper A et al Evaluation of elastomeric and electronic medication pumps at an outpatient cancer center. Available at www.omnimedicalsupply.com/Northshore_Dosi-Fuser_Study.pdf. Accessed 22 Jan 2016
Commission des tarifs médicaux LAA Tarif des soins infirmiers SBK-ASI. Available at www.mtk-ctm.ch/fr/tarifs/tarif-des-soins-infirmiers-sbk-asi/ Accessed 22 Jan 2016
Chapman ALN, Dixon S, Andrews D et al (2009) Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. J Antimicrob Chemother 64:1316–1324
Pajarón M, Fernández-Miera MF, Allende I et al (2015) Self-administered outpatient parenteral antimicrobial therapy (S-OPAT) for infective endocarditis: A safe and effective model. Eur J Int Med 26:131–136
Viaene E, Chanteux H, Servais H et al (2002) Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units). Antimicrob Agents Chemother 46:2327–2332
Arlicot N, Rochefort GY, Schlecht D et al (2007) Stability of antibiotics in portable pumps used for bronchial superinfection: guidelines for prescribers. Pediatrics 120:1255–1259
Zeller V, Durand F, Kitzis M-D et al (2009) Continuous cefazolin infusion to treat bone and joint infections: clinical efficacy, feasibility, safety, and serum and bone concentrations. Antimicrob Agents Chemother 53:883–887
Acknowledgments
The authors would like to acknowledge all of the OPAT nursing staff and Tony Chapman for his critical reading.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
The initiation of the OPAT unit of the University Hospital of Lausanne was supported by a grant from the Swiss Society of General Internal Medicine Foundation.
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Gardiol, C., Voumard, R., Cochet, C. et al. Setting up an outpatient parenteral antimicrobial therapy (OPAT) unit in Switzerland: review of the first 18 months of activity. Eur J Clin Microbiol Infect Dis 35, 839–845 (2016). https://doi.org/10.1007/s10096-016-2606-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-016-2606-z